Zanubrutinib Impurities and its Related Products



Displaying 13 results of Zanubrutinib Impurities

Zanubrutinib is a potent inhibitor of Bruton's tyrosine kinase (BTK) used in the treatment of certain types of cancer. Zanubrutinib impurities are unwanted substances that may be present in the drug product or raw material used to make it. These impurities can potentially affect the safety and efficacy of the drug, and therefore, their identification and control are critical in the drug development process. Common impurities in Zanubrutinib include related compounds, process-related impurities, and degradation products. Their levels must be monitored and controlled to ensure the quality of the drug product.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
(R)-Zanubrutinib Impurities CS-O-47725 1691249-44-1 Enquire
Chloropropanoyl Zanubrutinib Impurity Impurities CS-EO-03112 1633351-79-7 Enquire
N-Nitroso Zanubrutinib Desacryloyl impurity 2 Impurities CS-O-53881 Not Available Enquire
Rac-Zanubrutinib 4-acryloyl Impurity Impurities CS-O-49680 Not Available Enquire
Rac-Zanubrutinib Acid Impurity Impurities CS-O-49682 Not Available Enquire
Rac-Zanubrutinib Di acryloyl Impurity Impurities CS-O-49681 Not Available Enquire
Rac-Zanubrutinib Dimer impurity Impurities CS-O-51889 Not Available Enquire
Rac-Zanubrutinib Regioisomer Impurity Impurities CS-O-49683 Not Available Enquire
Zanubrutinib Cyano Impurity Impurities CS-EO-03113 2432022-47-2 Enquire
Zanubrutinib Dimer impurity Impurities CS-O-56847 Not Available Enquire
Zanubrutinib Dimer impurity Impurities CS-O-47726 Not Available Enquire
Zanubrutinib Mesyl impurity Impurities CS-O-47727 Not Available Enquire
Zanubrutinib n-Nitroso impurity Impurities CS-O-41996 Not Available Enquire